Hologic, Inc (NASDAQ: HOLX) has a higher price-to-earnings ratio of 19.16x compared to its average ratio. HOLX has 36-month beta value of 0.54. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 4 as “overweight,” 14 as “hold,” and 0 as “sell.”
The public float for HOLX is 222.47M, and currently, short sellers hold a 2.64% ratio of that float. The average trading volume of HOLX on April 03, 2025 was 2.44M shares.
HOLX) stock’s latest price update
Hologic, Inc (NASDAQ: HOLX) has experienced a decline in its stock price by -1.34 compared to its previous closing price of 61.38. However, the company has seen a fall of -1.50% in its stock price over the last five trading days. zacks.com reported 2025-03-31 that Hologic (HOLX) reachead $61.77 at the closing of the latest trading day, reflecting a +0.73% change compared to its last close.
HOLX’s Market Performance
Hologic, Inc (HOLX) has seen a -1.50% fall in stock performance for the week, with a -2.79% decline in the past month and a -16.20% plunge in the past quarter. The volatility ratio for the week is 1.78%, and the volatility levels for the past 30 days are at 2.30% for HOLX. The simple moving average for the last 20 days is -2.09% for HOLX’s stock, with a simple moving average of -18.93% for the last 200 days.
Analysts’ Opinion of HOLX
Leerink Partners, on the other hand, stated in their research note that they expect to see HOLX reach a price target of $75, previously predicting the price at $80. The rating they have provided for HOLX stocks is “Market Perform” according to the report published on February 06th, 2025.
HOLX Trading at -6.61% from the 50-Day Moving Average
After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.48% of loss for the given period.
Volatility was left at 2.30%, however, over the last 30 days, the volatility rate increased by 1.78%, as shares sank -2.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.94% lower at present.
During the last 5 trading sessions, HOLX fell by -1.50%, which changed the moving average for the period of 200-days by -16.05% in comparison to the 20-day moving average, which settled at $61.85. In addition, Hologic, Inc saw -15.99% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HOLX starting from Mitchell Essex D, who sale 24,856 shares at the price of $76.34 back on Dec 04 ’24. After this action, Mitchell Essex D now owns 27,957 shares of Hologic, Inc, valued at $1,897,482 using the latest closing price.
Mitchell Essex D, the Officer of Hologic, Inc, proposed sale 24,856 shares at $76.34 during a trade that took place back on Dec 04 ’24, which means that Mitchell Essex D is holding shares at $1,897,484 based on the most recent closing price.
Stock Fundamentals for HOLX
Current profitability levels for the company are sitting at:
- 0.24 for the present operating margin
- 0.56 for the gross margin
The net margin for Hologic, Inc stands at 0.18. The total capital return value is set at 0.13. Equity return is now at value 15.78, with 8.65 for asset returns.
Based on Hologic, Inc (HOLX), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 26.81. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 7.64.
Currently, EBITDA for the company is 1.3 billion with net debt to EBITDA at -1.29. When we switch over and look at the enterprise to sales, we see a ratio of 2.93. The receivables turnover for the company is 6.4for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.49.
Conclusion
To put it simply, Hologic, Inc (HOLX) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
